baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Soc. Generale Knock-Out iShares N.../ DE000SQ1RFJ1 /

2024-05-28 12:04:00 PM	Chg.+0.020	Bid12:05:59 PM	Ask-	Underlying	Strike price	Expiration date	Option type
2.290EUR	+0.88%	2.290 Bid Size: 8,000	- Ask Size: -	-	111.2653 USD	2078-12-31	Call

GlobeNewswire 9:00 AM TILT Biotherapeutics Presents Clinical Data on TILT-123 in Ovarian Cancer at ASCO 2024

GlobeNewswire 05-27 Cellectis to Report First Quarter 2024 Financial Results on May 28, 2024

GlobeNewswire 05-23 Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

GlobeNewswire 05-21 Sana Biotechnology Highlights Publication in Nature Biotechnology of Novel In Vivo Preclinical Data ...

GlobeNewswire 05-21 Pattern to Present at 2024 BIO International Convention

GlobeNewswire 05-20 LIXTE Biotechnology Holdings Provides Update on Recent Activities

Newsfile Corp 05-15 Maxwell Biosciences CEO J. Scotch McClure Named Top 25 Executive in Biotechnology

GlobeNewswire 05-14 UNITY Biotechnology, Inc. Reports First Quarter 2024 Financial Results and Business Updates

GlobeNewswire 05-09 Curia and Carterra Partner on Biologics Symposium to Further Biotechnology Research in the Pacific N...

GlobeNewswire 05-08 Sana Biotechnology Reports First Quarter 2024 Financial Results and Business Updates

GlobeNewswire 05-08 Siren Biotechnology and Catalent Enter Partnership for Manufacturing of AAV Gene Therapies for Cance...

GlobeNewswire 05-08 LIXTE Biotechnology Co-Sponsoring International Scientific Conference on “Therapeutic Over-Activatio...

GlobeNewswire 05-06 Sana Biotechnology to Present at May and June 2024 Investor Conferences

GlobeNewswire 05-03 PDS Biotechnology Announces Details of Virtual KOL Event

GlobeNewswire 04-30 Nautilus Biotechnology Reports First Quarter 2024 Financial Results

GlobeNewswire 04-25 UNITY Biotechnology Announces Upcoming Presentations at the ARVO 2024 Annual Meeting

GlobeNewswire 04-23 UNITY Biotechnology Announces Extension of Phase 2b ASPIRE Clinical Study Evaluating UBX1325 in DME

GlobeNewswire 04-16 Turnstone Biologics Appoints William Waddill to its Board of Directors

GlobeNewswire 04-16 Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Dir...

GlobeNewswire 04-15 UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Business U...

GlobeNewswire 04-15 Regeneron Ventures Launches with $500 Million Commitment to Fuel Promising Biotechnology Innovation

GlobeNewswire 04-11 Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024

GlobeNewswire 04-09 Hemp, Inc. Welcomes USDA Approval of GMO Hemp Strain – A Step Forward in Cannabis Biotechnology

GlobeNewswire 03-22 Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors

Newsfile Corp 03-22 Jamie Metzl to Speak on AI, Genetics, and Biotechnology Revolutions at the Global AI Show

Soc. Generale Knock-Out iShares N.../ DE000SQ1RFJ1 /

If you wish to receive reply to your feedback, please provide your email address.